NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BoM and certain of its officers and/or directors have […]
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Ford Motor Company (NYSE:F) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ford-lawsuit-submission-form?prid=103931&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Arbor Realty Trust, Inc. (NYSE:ABR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/arbor-lawsuit-submission-form?prid=103930&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Extreme Networks, Inc. (NASDAQ:EXTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/extreme-networks-inc-lawsuit-submission-form?prid=103929&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice and data satellite communications, today announced that its Board of Directors has authorized the repurchase of an additional $500 million of Iridium common stock through December 31, 2027. This is the fourth stock repurchase authorization from the Board of Directors in the past four
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit at 11:00 a.m. Eastern Time on Thursday, September 26, 2024. Chief Business Development and Strategy Officer and CEO-elect Kyle Gano and Vice-President of Investor Relations Todd Tushla will present at the conference. https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.jpg The live presentation
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Under Armour, Inc. ("Under Armour, Inc.") (NYSE:UA) concerning possible violations of federal securities laws. Under Armour issued a press release on September 9, 2024, "announc[ing] an update to its Fiscal 2025 restructuring plan,
LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” or “we”), a leading global, vertically integrated provider of thermal imaging cores, custom optical assemblies, photonics and infrared solutions for the industrial, commercial, defense, telecommunications, and medical industries, today announced financial results for its fiscal 2024 fourth quarter and full year ended June 30, 2024. https://mma.prnewswire.com/media/2510046/LightPath_Technologies_Logo.jpg Fiscal
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your GitLab Inc. (NASDAQ:GTLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gitlab-lawsuit-submission-form?prid=103927&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
Texas Instruments Incorporated (TI) (Nasdaq: TXN) today said it will raise its quarterly cash dividend 5%, from $1.30 per share to $1.36, or $5.44 annualized. The higher dividend will be payable November 12, 2024, to stockholders of record on October 31, 2024, contingent upon formal declaration by the board of directors at its regular meeting